AIMC Topic: Deprescriptions

Clear Filters Showing 1 to 2 of 2 articles

Mobile applications on app stores for deprescribing: A scoping review.

British journal of clinical pharmacology
Deprescribing is an evidence-based intervention to reduce potentially inappropriate medication use. Yet its implementation faces barriers including inadequate resources, training and time. Mobile applications (apps) on app stores could address some b...

Clinical decision-making in benzodiazepine deprescribing by healthcare providers vs. AI-assisted approach.

British journal of clinical pharmacology
AIMS: The aim of this study was to compare the clinical decision-making for benzodiazepine deprescribing between a healthcare provider (HCP) and an artificial intelligence (AI) chatbot GPT4 (ChatGPT-4).